Aromatic L-amino acid decarboxylase — Drug Target

All drugs that target Aromatic L-amino acid decarboxylase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Aromatic L-amino acid decarboxylase inhibitor

Phase 2 pipeline (1)

• Carbidopa High-Dose · NYU Langone Health · Aromatic L-amino acid decarboxylase inhibitor · Movement Disorders
  Carbidopa is a decarboxylase inhibitor that prevents the conversion of levodopa to dopamine, thereby increasing the availability of levodopa in the brain.